Nivalis Therapeutics, Inc. Email Format

PharmaceuticalsColorado, United States11-50 Employees

Nivalis Therapeutics, Inc. is a pharmaceutical company based in Boulder, Colorado, that has progressed from early-stage, preclinical work to a clinical-stage focus aimed at translating laboratory science into patient benefit. The company operates in a small-to-mid sized organizational context, and its work centers on developing solutions for the cystic fibrosis community, reflecting its emphasis on advancing therapies to improve and extend patients’ lives. Historically, the firm underwent a merger with Alpine Immune Sciences in 2017 and has used a name change from N30 Pharmaceuticals to Nivalis to signal its evolving identity and mission. A notable recent development involves leadership changes in 2021, with the assignment of interim executive roles at another organization, indicating ongoing leadership transitions. The company’s operations and location are anchored in Boulder, within the broader pharmaceutical manufacturing landscape, and its trajectory shows a shift from exploration to clinical development as it seeks to address unmet needs in CF management.

Get verified Nivalis Therapeutics, Inc. emails free

Company overview Employee directory